VELMA HUGHES: Open Payments
NPI 1144717547 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 10 payments from 5 companies in 2025. Trend: 2023 $10,320 · 2024 $1,571 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $94 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: INGREZZA, AUSTEDO XR, REXULTI, TRINTELLIX, Auvelity.
Industry payments across TX — which companies pay providers there.
